ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 50 filers reported holding ODONATE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $171,000 | -63.6% | 58,683 | -56.4% | 0.00% | – |
| Q2 2021 | $470,000 | +85.0% | 134,633 | +81.6% | 0.00% | – |
| Q1 2021 | $254,000 | -76.7% | 74,149 | +30.7% | 0.00% | – |
| Q4 2020 | $1,090,000 | +19.9% | 56,719 | -9.5% | 0.00% | – |
| Q3 2020 | $909,000 | +178.8% | 62,671 | +713.1% | 0.00% | – |
| Q2 2020 | $326,000 | -57.2% | 7,708 | -72.1% | 0.00% | – |
| Q1 2020 | $762,000 | +97.9% | 27,587 | +132.7% | 0.00% | – |
| Q4 2019 | $385,000 | +285.0% | 11,855 | +208.4% | 0.00% | – |
| Q3 2019 | $100,000 | -79.8% | 3,844 | -72.7% | 0.00% | – |
| Q2 2019 | $495,000 | -44.1% | 14,093 | -64.8% | 0.00% | – |
| Q1 2019 | $886,000 | +336.5% | 40,058 | +177.9% | 0.00% | – |
| Q4 2018 | $203,000 | +0.5% | 14,417 | +38.5% | 0.00% | – |
| Q3 2018 | $202,000 | +12.8% | 10,410 | +28.4% | 0.00% | – |
| Q2 2018 | $179,000 | +517.2% | 8,108 | +495.3% | 0.00% | – |
| Q1 2018 | $29,000 | – | 1,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |